Literature DB >> 6790622

Structural studies of a human gamma 3 myeloma protein (Goe) that binds staph protein A.

B Recht, B Frangione, E Franklin, E van Loghem.   

Abstract

The partial amino acid sequence of the Fc region of an unusual monoclonal immunoglobulin molecule (Goe), which had the allotypic markers Gm (b0, b3, b5, s, t, v), rarely encountered in Caucasians, was determined. Protein Goe was previously shown to belong to the gamma 3 subclass by antigenic typing, to possess a gamma 3-like hinge region and a gamma 1-like carboxy-terminal octadecapeptide, and to bind to staphylococcal protein A. The sequence of protein Goe resembled that of gamma 3 molecules except for the presence of tyrosine at position 296, alanine at position 339, and histidine and tyrosine at positions 435 and 436. It is of interest that histidine 435 appears to play an important role in binding to Staph protein A. Since tyrosine and phenylalanine at 296 and 300 are typical of G3m(g) molecules, whereas protein Goe is G3m(g-), this may correspond to the non-b1 allotypic marker. Of the numerous explanations to account for these findings, the most likely possibilities are that protein Goe is either a hybrid molecule or the product of a germ line gene representing the G3m s allotype, which is rare in Caucasians and common in Mongoloid populations. Support for the latter alternative is provided by the isolation from normal serum of a small amount of a protein having many of the properties of protein Goe.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6790622

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  Opsonizing antibodies (IgG1) up-regulate monocyte proinflammatory cytokines tumour necrosis factor-alpha (TNF-alpha) and IL-6 but not anti-inflammatory cytokine IL-10 in mycobacterial antigen-stimulated monocytes-implications for pathogenesis.

Authors:  R Hussain; H Shiratsuchi; M Phillips; J Ellner; R S Wallis
Journal:  Clin Exp Immunol       Date:  2001-02       Impact factor: 4.330

2.  A human IgG 3 is opsonic in vitro against type III group B streptococci.

Authors:  J S Kim; K S Kim; C A Wass; J A Short; D C Heiner
Journal:  J Clin Immunol       Date:  1990-05       Impact factor: 8.317

3.  Sequence of a human immunoglobulin gamma 3 heavy chain constant region gene: comparison with the other human C gamma genes.

Authors:  S Huck; P Fort; D H Crawford; M P Lefranc; G Lefranc
Journal:  Nucleic Acids Res       Date:  1986-02-25       Impact factor: 16.971

4.  DNA sequences specific for Caucasian G3m(b) and (g) allotypes: allotyping at the genomic level.

Authors:  M Balbín; A Grubb; G G de Lange; R Grubb
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

Review 5.  Hybrid Ig molecules: implication for current theories on immunoglobulin synthesis and evolution.

Authors:  A C Wang; I Y Wang
Journal:  Surv Immunol Res       Date:  1983

6.  The effect of paraprotein on platelet aggregation.

Authors:  Irena Djunic; Ivo Elezovic; Vesna Ilic; Nadezda Milosevic-Jovcic; Jelena Bila; Nada Suvajdzic-Vukovic; Darko Antic; Ana Vidovic; Dragica Tomin
Journal:  J Clin Lab Anal       Date:  2014-01-06       Impact factor: 2.352

7.  Structural comparison of HIV-1 envelope spikes with and without the V1/V2 loop.

Authors:  Guiqing Hu; Jun Liu; Kenneth A Taylor; Kenneth H Roux
Journal:  J Virol       Date:  2010-12-29       Impact factor: 5.103

8.  Binding site and subclass specificity of the herpes simplex virus type 1-induced Fc receptor.

Authors:  D Wiger; T E Michaelsen
Journal:  Immunology       Date:  1985-03       Impact factor: 7.397

9.  Studies of protein A and herpes simplex virus-1 induced Fc gamma-binding specificities. Different binding patterns for IgG3 from Caucasian and Oriental subjects.

Authors:  P J Johansson; T Ota; N Tsuchiya; C C Malone; R C Williams
Journal:  Immunology       Date:  1994-12       Impact factor: 7.397

10.  gamma Heavy chain disease in man: cDNA sequence supports partial gene deletion model.

Authors:  A Alexander; M Steinmetz; D Barritault; B Frangione; E C Franklin; L Hood; J N Buxbaum
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.